Novel pharmacological approaches to combat obesity and insulin resistance: Targeting skeletal muscle with 'exercise mimetics'

Diabetologia

Volumn 52, Issue 10, 2009, Pages 2015-2026

  Carey, A L ^a   Kingwell, B A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

AMPK; Metabolic syndrome; PGC 1 ; Physical activity; PPAR; Review; SIRT1; Skeletal muscle; Training; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 5' AMP ACTIVATED PROTEIN KINASE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; CAFFEINE; GLUCAGON LIKE PEPTIDE 1; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE; RIMONABANT; SIBUTRAMINE; SULFONYLUREA; TETRAHYDROLIPSTATIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SILENT INFORMATION REGULATOR OF TRANSCRIPTION; UNCLASSIFIED DRUG;

ACIDOSIS; BARIATRIC SURGERY; BODY FAT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; DIET THERAPY; DRUG EFFICACY; ENDURANCE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; LIFESTYLE; MALABSORPTION; METABOLIC DISORDER; MOOD DISORDER; MUSCLE EXERCISE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PHYSICAL DISEASE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SIDE EFFECT; SKELETAL MUSCLE; STOMACH BYPASS; WEIGHT GAIN;

EXERCISE; HUMANS; INSULIN RESISTANCE; MUSCLE, SKELETAL; OBESITY; SIGNAL TRANSDUCTION;

EID: 69949162866     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1420-x     Document Type: Review

References (100)

1. WP James 2008 The epidemiology of obesity: the size of the problem J Intern Med 263 336 352
2. FW Booth SJ Lees 2007 Fundamental questions about genes, inactivity, and chronic diseases Physiol Genomics 28 146 157
3. SH Schneider NB Ruderman 1986 Exercise and physical training in the treatment of diabetes mellitus Compr Ther 12 49 56
4. MT Hamilton FW Booth 2000 Skeletal muscle adaptation to exercise: a century of progress J Appl Physiol 88 327 331
5. PE O'Brien WA Brown JB Dixon 2005 Obesity, weight loss and bariatric surgery Med J Aust 183 310 314
6. JA Tice L Karliner J Walsh AJ Petersen MD Feldman 2008 Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures Am J Med 121 885 893
7. S Troy M Soty L Ribeiro, et al. 2008 Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice Cell Metab 8 201 211
8. A Clegg J Colquitt M Sidhu P Royle A Walker 2003 Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation Int J Obes Relat Metab Disord 27 1167 1177
9. JB Dixon PE O'Brien J Playfair, et al. 2008 Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial JAMA 299 316 323
10. RF Kushner CA Noble 2006 Long-term outcome of bariatric surgery: an interim analysis Mayo Clin Proc 81 S46 51
11. RS Padwal SR Majumdar 2007 Drug treatments for obesity: orlistat, sibutramine, and rimonabant Lancet 369 71 77
12. P Raskin 2008 Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes Diabetes Metab Res Rev 24 3 13
13. S Bolen L Feldman J Vassy, et al. 2007 Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus Ann Intern Med 147 386 399
14. WC Knowler E Barrett-Connor SE Fowler, et al. 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 393 403
15. SJ Lessard DA Rivas ZP Chen, et al. 2007 Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance Diabetes 56 1856 1864
16. D Luft RM Schmulling M Eggstein 1978 Lactic acidosis in biguanide-treated diabetics: a review of 330 cases Diabetologia 14 75 87
17. SE Nissen K Wolski 2007 Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2457 2471 (Pubitemid 46919772)
18. M Teran-Garcia T Rankinen RA Koza DC Rao C Bouchard 2005 Endurance training-induced changes in insulin sensitivity and gene expression Am J Physiol Endocrinol Metab 288 E1168 E1178
19. CR Bruce AD Kriketos GJ Cooney JA Hawley 2004 Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes Diabetologia 47 23 30
20. G Jennings L Nelson P Nestel, et al. 1986 The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity Circulation 73 30 40
21. JF Wojtaszewski EA Richter 2006 Effects of acute exercise and training on insulin action and sensitivity: focus on molecular mechanisms in muscle Essays Biochem 42 31 46
22. LJ Goodyear 2008 The exercise pill-too good to be true? N Engl J Med 359 1842 1844
23. RR Wing 1999 Physical activity in the treatment of the adulthood overweight and obesity: current evidence and research issues Med Sci Sports Exerc 31 S547 S552
24. EA Richter NB Ruderman 2009 AMPK and the biochemistry of exercise: implications for human health and disease Biochem J 418 261 275
25. LJ Goodyear PY Chang DJ Sherwood SD Dufresne DE Moller 1996 Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle Am J Physiol 271 E403 E408
26. R Hernando R Manso 1997 Muscle fibre stress in response to exercise: synthesis, accumulation and isoform transitions of 70-kDa heat-shock proteins Eur J Biochem 243 460 467
27. RC Walsh I Koukoulas A Garnham PL Moseley M Hargreaves MA Febbraio 2001 Exercise increases serum Hsp72 in humans Cell Stress Chaperones 6 386 393
28. K Baar AR Wende TE Jones, et al. 2002 Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1 FASEB J 16 1879 1886
29. M Goto S Terada M Kato, et al. 2000 cDNA cloning and mRNA analysis of PGC-1 in epitrochlearis muscle in swimming-exercised rats Biochem Biophys Res Commun 274 350 354
30. DK Kramer L Al-Khalili B Guigas Y Leng PM Garcia-Roves A Krook 2007 Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle J Biol Chem 282 19313 19320
31. KJ Rodnick EJ Henriksen DE James JO Holloszy 1992 Exercise training, glucose transporters, and glucose transport in rat skeletal muscles Am J Physiol 262 C9 C14
32. A Bonen DJ Dyck A Ibrahimi NA Abumrad 1999 Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36 Am J Physiol 276 E642 E649
33. M Fluck MN Waxham MT Hamilton FW Booth 2000 Skeletal muscle Ca(2+)-independent kinase activity increases during either hypertrophy or running J Appl Physiol 88 352 358
34. 2+ calmodulin-dependent protein kinase II expression and signalling in skeletal muscle of humans J Physiol 583 785 795
35. KS Rockl CA Witczak LJ Goodyear 2008 Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise IUBMB Life 60 145 153
36. AJ Rose BJ Michell BE Kemp M Hargreaves 2004 Effect of exercise on protein kinase C activity and localization in human skeletal muscle J Physiol 561 861 870 (Pubitemid 40074940)
37. BK Pedersen MA Febbraio 2008 Muscle as an endocrine organ: focus on muscle-derived interleukin-6 Physiol Rev 88 1379 1406
38. R Bergeron SF Previs GW Cline, et al. 2001 Effect of 5-aminoimidazole-4- carboxamide-1-beta-d-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats Diabetes 50 1076 1082
39. T Hayashi MF Hirshman EJ Kurth WW Winder LJ Goodyear 1998 Evidence for 5 AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport Diabetes 47 1369 1373
40. SB Jorgensen JT Treebak B Viollet, et al. 2007 Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle Am J Physiol Endocrinol Metab 292 E331 E339
41. SB Jorgensen JF Wojtaszewski B Viollet, et al. 2005 Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle FASEB J 19 1146 1148
42. J Chung AK Nguyen DC Henstridge, et al. 2008 HSP72 protects against obesity-induced insulin resistance Proc Natl Acad Sci U S A 105 1739 1744
43. C Handschin S Chin P Li, et al. 2007 Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals J Biol Chem 282 30014 30021
44. RV Farese MP Sajan H Yang, et al. 2007 Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes J Clin Invest 117 2289 2301
45. 2+/calmodulin-dependent kinases in skeletal muscle plasticity J Appl Physiol 99 414 423
46. J Hirosumi G Tuncman L Chang, et al. 2002 A central role for JNK in obesity and insulin resistance Nature 420 333 336
47. JK Kim YJ Kim JJ Fillmore, et al. 2001 Prevention of fat-induced insulin resistance by salicylate J Clin Invest 108 437 446
48. HF Kramer LJ Goodyear 2007 Exercise, MAPK, and NF-kappaB signaling in skeletal muscle J Appl Physiol 103 388 395
49. P Hakimi J Yang G Casadesus, et al. 2007 Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse J Biol Chem 282 32844 32855
50. M Lagouge C Argmann Z Gerhart-Hines, et al. 2006 Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 127 1109 1122
51. YX Wang CL Zhang RT Yu, et al. 2004 Regulation of muscle fiber type and running endurance by PPARdelta PLoS Biol 2 e294
52. A Coste JF Louet M Lagouge, et al. 2008 The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α Proc Natl Acad Sci U S A 105 17187 17192
53. DM Muoio PS [tmp] MacLean DB Lang, et al. 2002 Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta J Biol Chem 277 26089 26097
54. YX Wang CH Lee S Tiep, et al. 2003 Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity Cell 113 159 170
55. VA Narkar M Downes RT Yu, et al. 2008 AMPK and PPARdelta agonists are exercise mimetics Cell 134 405 415
56. M Vanttinen P Nuutila T Kuulasmaa, et al. 2005 Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake Diabetes 54 3587 3591
57. N Stefan C Thamer H Staiger, et al. 2007 Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention J Clin Endocrinol Metab 92 1827 1833
58. WR Oliver Jr JL Shenk MR Snaith, et al. 2001 A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport Proc Natl Acad Sci U S A 98 5306 5311
59. U Riserus D Sprecher T Johnson, et al. 2008 Activation of peroxisome proliferator-activated receptor (PPAR) delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men Diabetes 57 332 339
60. T Fritz DK Kramer HK Karlsson, et al. 2006 Low-intensity exercise increases skeletal muscle protein expression of PPARdelta and UCP3 in type 2 diabetic patients Diabetes Metab Res Rev 22 492 498
61. GR Steinberg SB Jorgensen 2007 The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity Mini Rev Med Chem 7 519 526
62. BG Drew SJ Duffy MF Formosa, et al. 2009 High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes Circulation 119 2103 2111
63. WE Kraus JA Houmard BD Duscha, et al. 2002 Effects of the amount and intensity of exercise on plasma lipoproteins N Engl J Med 347 1483 1492
64. ES Buhl N Jessen R Pold, et al. 2002 Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome Diabetes 51 2199 2206
65. MJ Watt GR Steinberg ZP Chen BE Kemp MA Febbraio 2006 Fatty acids stimulate AMP-activated protein kinase and enhance fatty acid oxidation in L6 myotubes J Physiol 574 139 147
66. P Garcia-Roves JM Huss DH Han, et al. 2007 Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle Proc Natl Acad Sci U S A 104 10709 10713
67. BG Drew BA Kingwell 2008 Acadesine, an adenosine-regulating agent with the potential for widespread indications Expert Opin Pharmacother 9 2137 2144
68. H Boon M Bosselaar SF Praet, et al. 2008 Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients Diabetologia 51 1893 1900
69. G Zhou R Myers Y Li, et al. 2001 Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108 1167 1174
70. JA Baur DA Sinclair 2006 Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 493 506
71. X Hou S Xu KA Maitland-Toolan, et al. 2008 SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase J Biol Chem 283 20015 20026
72. P Puigserver Z Wu CW Park R Graves M Wright BM Spiegelman 1998 A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 92 829 839
73. S Jager C Handschin J St-Pierre BM Spiegelman 2007 AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha Proc Natl Acad Sci U S A 104 12017 12022
74. F Lan JM Cacicedo N Ruderman Y Ido 2008 SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation J Biol Chem 283 27628 27635
75. SA Hawley J Boudeau JL Reid, et al. 2003 Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade J Biol 2 28
76. JN Feige M Lagouge C Canto, et al. 2008 Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metab 8 347 358
77. JC Milne PD Lambert S Schenk, et al. 2007 Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Nature 450 712 716
78. KJ Pearson JA Baur KN Lewis, et al. 2008 Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span Cell Metab 8 157 168
79. AE Civitarese S Carling LK Heilbronn, et al. 2007 Calorie restriction increases muscle mitochondrial biogenesis in healthy humans PLoS Med 4 e76
80. AS Mathai A Bonen CR Benton DL Robinson TE Graham 2008 Rapid exercise-induced changes in PGC-1alpha mRNA and protein in human skeletal muscle J Appl Physiol 105 1098 1105
81. H Pilegaard B Saltin PD Neufer 2003 Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle J Physiol 546 851 858
82. M Fanelli E Filippi F Sentinelli, et al. 2005 The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects Dis Markers 21 175 180
83. L Andrulionyte P Peltola JL Chiasson M Laakso 2006 Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial Diabetes 55 2148 2152
84. C Handschin BM Spiegelman 2008 The role of exercise and PGC1alpha in inflammation and chronic disease Nature 454 463 469
85. TE Graham DS Battram F Dela A El-Sohemy FS Thong 2008 Does caffeine alter muscle carbohydrate and fat metabolism during exercise? Appl Physiol Nutr Metab 33 1311 1318
86. 2+ and the sarcoplasmic reticulum J Mol Cell Cardiol 16 165 174
87. 2+-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle J Appl Physiol 104 1366 1373
88. DC Wright PC Geiger DH Han TE Jones JO Holloszy 2007 Calcium induces increases in peroxisome proliferator-activated receptor gamma coactivator-1alpha and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation J Biol Chem 282 18793 18799
89. T Murase S Haramizu A Shimotoyodome I Tokimitsu T Hase 2006 Green tea extract improves running endurance in mice by stimulating lipid utilization during exercise Am J Physiol Regul Integr Comp Physiol 290 R1550 R1556
90. QF Collins HY Liu J Pi Z Liu MJ Quon W Cao 2007 Epigallocatechin-3- gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5-AMP-activated protein kinase J Biol Chem 282 30143 30149
91. JT Hwang J Ha IJ Park, et al. 2007 Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway Cancer Lett 247 115 121
92. MC Gomez-Cabrera E Domenech M Romagnoli, et al. 2008 Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance Am J Clin Nutr 87 142 149
93. AL Carey GR Steinberg SL Macaulay, et al. 2006 Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase Diabetes 55 2688 2697
94. DR Bolster SJ Crozier SR Kimball LS Jefferson 2002 AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling J Biol Chem 277 23977 23980
95. D Meley C Bauvy JH Houben-Weerts, et al. 2006 AMP-activated protein kinase and the regulation of autophagic proteolysis J Biol Chem 281 34870 34879
96. S Miura E Tomitsuka Y Kamei, et al. 2006 Overexpression of peroxisome proliferator-activated receptor gamma co-activator-1alpha leads to muscle atrophy with depletion of ATP Am J Pathol 169 1129 1139
97. BA Kingwell GL Jennings 1993 Effects of walking and other exercise programs upon blood pressure in normal subjects Med J Aust 158 234 238
98. T Church SN Blair 2009 When will we treat physical activity as a legitimate medical therapy... even though it does not come in a pill? Br J Sports Med 43 80 81
99. JA Hawley JO Holloszy 2009 Exercise: It's the real thing! Nutr Rev 67 172 178
100. EA Richter B Kiens JF Wojtaszewski 2008 Can exercise mimetics substitute for exercise? Cell Metab 8 96 98